*Some Market data delayed by 15 mins.

Sensei Biotherapeutics, Inc. Common Stock

Symbol: SNSE (NASDAQ)
9.75 ▲ (3.17%) 0.300

Company Description:
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Key Stats
  • Today's Open: $9.413
  • Today's High: $9.98
  • Today's Low: $9.245
  • Today's Volume: 8.77K
  • Yesterday Close: $9.45
  • Yesterday High: $9.4997
  • Yesterday Low: $9.2406
  • Yesterday Volume: 2.35K
  • Last Min Volume: 0
  • Last Min High: $9.942
  • Last Min Low: $9.75
  • Last Min VWAP: $0
Company Profile
  • Name: Sensei Biotherapeutics, Inc. Common Stock
  • Website: https://www.senseibio.com
  • Listed Date: 2021-02-04
  • Location: ROCKVILLE, MD
  • Market Status: Active
  • CIK Number: 0001829802
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $11.92M
  • Round Lot: 100
  • Outstanding Shares: 1.26M
  • Asset Type: CS
RECENT FILINGS FOR SNSE
Filing Date Filing Type Format
2025-08-05 10-Q View
2025-08-05 8-K View
2025-07-09 8-K View
2025-06-13 8-K View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 8-K View
2025-05-06 10-Q View
2025-05-06 8-K View
2025-04-11 ARS View
2025-04-11 DEFA14A View
2025-04-11 DEF 14A View
2025-04-01 PRE 14A View
2025-03-28 S-8 View
2025-03-28 10-K View
2025-03-28 8-K View
Latest News on SNSE

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.